Annual Total Expenses
$971.13 M
+$108.73 M+12.61%
December 31, 2024
Summary
- As of February 26, 2025, RPRX annual total expenses is $971.13 million, with the most recent change of +$108.73 million (+12.61%) on December 31, 2024.
- During the last 3 years, RPRX annual total expenses has risen by +$112.38 million (+13.09%).
- RPRX annual total expenses is now -26.11% below its all-time high of $1.31 billion, reached on December 31, 2022.
Performance
RPRX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$232.13 M
+$402.51 M+236.24%
December 31, 2024
Summary
- As of February 26, 2025, RPRX quarterly total expenses is $232.13 million, with the most recent change of +$402.51 million (+236.24%) on December 31, 2024.
- Over the past year, RPRX quarterly total expenses has increased by +$248.96 million (+1479.41%).
- RPRX quarterly total expenses is now -63.83% below its all-time high of $641.75 million, reached on March 31, 2024.
Performance
RPRX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
RPRX Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +12.6% | +1479.4% |
3 y3 years | +13.1% | +1479.4% |
5 y5 years | +220.1% | +1479.4% |
RPRX Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -26.1% | +13.1% | -63.8% | +236.2% |
5 y | 5-year | -26.1% | +220.1% | -63.8% | +126.5% |
alltime | all time | -26.1% | +220.1% | -63.8% | +126.5% |
Royalty Pharma Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $971.13 M(+12.6%) | $232.13 M(-236.2%) |
Sep 2024 | - | -$170.38 M(-163.7%) |
Jun 2024 | - | $267.64 M(-58.3%) |
Mar 2024 | - | $641.75 M(-3913.6%) |
Dec 2023 | $862.40 M(-34.4%) | -$16.83 M(-104.4%) |
Sep 2023 | - | $384.87 M(+33.0%) |
Jun 2023 | - | $289.36 M(+41.2%) |
Mar 2023 | - | $205.00 M(-52.6%) |
Dec 2022 | $1.31 B(+53.1%) | $432.58 M(+13.5%) |
Sep 2022 | - | $381.25 M(+141.1%) |
Jun 2022 | - | $158.16 M(-53.8%) |
Mar 2022 | - | $342.33 M(-18.9%) |
Dec 2021 | $858.75 M | $422.28 M(+49.4%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $282.72 M(-248.8%) |
Jun 2021 | - | -$189.99 M(-155.3%) |
Mar 2021 | - | $343.73 M(+78.1%) |
Dec 2020 | $461.90 M(-157.1%) | $193.03 M(+593.6%) |
Sep 2020 | - | $27.83 M(-72.6%) |
Jun 2020 | - | $101.59 M(-27.2%) |
Mar 2020 | - | $139.45 M(-115.9%) |
Dec 2019 | -$808.92 M(-287.9%) | -$874.43 M(+1181.8%) |
Sep 2019 | - | -$68.22 M(-152.6%) |
Jun 2019 | - | $129.75 M(+3157.6%) |
Mar 2019 | - | $3.98 M |
Dec 2018 | $430.45 M(-34.6%) | - |
Dec 2017 | $658.24 M | - |
FAQ
- What is Royalty Pharma annual total expenses?
- What is the all time high annual total expenses for Royalty Pharma?
- What is Royalty Pharma annual total expenses year-on-year change?
- What is Royalty Pharma quarterly total expenses?
- What is the all time high quarterly total expenses for Royalty Pharma?
- What is Royalty Pharma quarterly total expenses year-on-year change?
What is Royalty Pharma annual total expenses?
The current annual total expenses of RPRX is $971.13 M
What is the all time high annual total expenses for Royalty Pharma?
Royalty Pharma all-time high annual total expenses is $1.31 B
What is Royalty Pharma annual total expenses year-on-year change?
Over the past year, RPRX annual total expenses has changed by +$108.73 M (+12.61%)
What is Royalty Pharma quarterly total expenses?
The current quarterly total expenses of RPRX is $232.13 M
What is the all time high quarterly total expenses for Royalty Pharma?
Royalty Pharma all-time high quarterly total expenses is $641.75 M
What is Royalty Pharma quarterly total expenses year-on-year change?
Over the past year, RPRX quarterly total expenses has changed by +$248.96 M (+1479.41%)